Additionally, while we have previously shown that causal BRCA1/2 PVs were exclusively detected in high-grade serous/high-grade endometrioid carcinoma [17], selectively testing these tumors requires accurate histopathological diagnosis and possibly central pathology reviews, which is not structurally implemented before testing. This evidence concerns the gene BRCA1 and endometrioid adenocarcinoma.